Beatrice M. Szantyr
Research Subjects
Beatrice M. Szantyr has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Christine Green
Family Medicine, Green Oaks Medical Center, Mountain View, CA 94040, USA
1 shared publication - Elizabeth Louise Maloney
Partnership for Tick-Borne Diseases Education, P.O. Box 84, Wyoming, MN 55092, USA
1 shared publication - Joseph Jr. Burrascano
IGeneX Reference Laboratory, Milpitas, CA 95035, USA
1 shared publication - Kenneth B. Liegner
P.C. Lyme Borreliosis & Related Disorders, 592 Route 22, Suite 1B, Pawling, NY 12564, USA
1 shared publication - Robert C. Bransfield
Rutgers-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA
1 shared publication - Samuel M. Shor
Internal Medicine of Northern Virginia, George Washington University Health Care Sciences’, 1860 Town Center Drive #G220, Reston, VA 20191, USA
1 shared publication
Latest Publications
- 3 March 2022
- Published by Elsevier in The American Journal of Medicine
- Vol. 135 (3) , e77-E77
Response to Commentary Promoting the New Lyme Disease Guidelines
- 3 March 2022
- Published by Elsevier in The American Journal of Medicine
- Vol. 135 (3) , e77-E77
Response to Commentary Promoting the New Lyme Disease Guidelines
- Open Access
- 16 December 2019
- Published by MDPI AG in Antibiotics
- Vol. 8 (4) , 269
Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group
Objective: Chronic Lyme disease has been a poorly defined term and often dismissed as a fictitious entity. In this paper, the International Lyme and Associated Diseases Society (ILADS) provides its evidence-based definition of chronic Lyme disease. Definition: ILADS defines chronic Lyme disease (CLD) as a multisystem illness with a wide range of symptoms and/or signs that are either continuously or intermittently present for a minimum of six months. The illness is the result of an active and ongoing infection by any of several pathogenic members of the Borrelia burgdorferi sensu lato complex (Bbsl). The infection has variable latency periods and signs and symptoms may wax, wane and migrate. CLD has two subcategories, CLD, untreated (CLD-U) and CLD, previously treated (CLD-PT). The latter requires that CLD manifestations persist or recur following treatment and are present continuously or in a relapsing/remitting pattern for a duration of six months or more. Methods: Systematic review of over 250 peer reviewed papers in the international literature to characterize the clinical spectrum of CLD-U and CLD-PT. Conclusion: This evidence-based definition of chronic Lyme disease clarifies the term’s meaning and the literature review validates that chronic and ongoing Bbsl infections can result in chronic disease. Use of this CLD definition will promote a better understanding of the infection and facilitate future research of this infection.
- 16 December 2019
- Published by MDPI AG in Antibiotics
- Vol. 8 (4) , 269
Open AccessChronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group
Objective: Chronic Lyme disease has been a poorly defined term and often dismissed as a fictitious entity. In this paper, the International Lyme and Associated Diseases Society (ILADS) provides its evidence-based definition of chronic Lyme disease. Definition: ILADS defines chronic Lyme disease (CLD) as a multisystem illness with a wide range of symptoms and/or signs that are either continuously or intermittently present for a minimum of six months. The illness is the result of an active and ongoing infection by any of several pathogenic members of the Borrelia burgdorferi sensu lato complex (Bbsl). The infection has variable latency periods and signs and symptoms may wax, wane and migrate. CLD has two subcategories, CLD, untreated (CLD-U) and CLD, previously treated (CLD-PT). The latter requires that CLD manifestations persist or recur following treatment and are present continuously or in a relapsing/remitting pattern for a duration of six months or more. Methods: Systematic review of over 250 peer reviewed papers in the international literature to characterize the clinical spectrum of CLD-U and CLD-PT. Conclusion: This evidence-based definition of chronic Lyme disease clarifies the term’s meaning and the literature review validates that chronic and ongoing Bbsl infections can result in chronic disease. Use of this CLD definition will promote a better understanding of the infection and facilitate future research of this infection.